Cargando…
Tumour necrosis factor blockade and the risk of osteoporosis: back to the future
Osteoporosis is a common clinical problem, especially in patients with rheumatoid arthritis (RA). A reduction in bone mineral density (BMD) of the axial and appendicular skeleton ranging from 7% to 15% has been reported in RA in studies employing a variety of densitometric techniques. Reports consis...
Autor principal: | Sambrook, Philip |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206379/ https://www.ncbi.nlm.nih.gov/pubmed/17850677 http://dx.doi.org/10.1186/ar2277 |
Ejemplares similares
-
Back to the Future With Co-Stimulation Blockade
por: Flechner, Stuart M., et al.
Publicado: (2023) -
Epidemiology of osteoporosis and fractures in ankylosing spondylitis
por: Sambrook, Philip N
Publicado: (2012) -
Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Sambrook, Philip
Publicado: (2007) -
Back to the future?
por: Heim, Christian
Publicado: (2023) -
Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)